| Glucose transporter type 1 deficiency syndrome with carbohydrate-responsive symptoms but without epilepsy. | |
| | |
MedLine Citation:
|
PMID: 21838819 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
Glucose transporter type 1 deficiency syndrome (GLUT1-DS) is caused by a defect in glucose transport across the blood-brain barrier. The main symptoms are epilepsy, developmental delay, movement disorders, and deceleration of head circumference. A ketogenic diet has been shown to be effective in controlling epilepsy in GLUT1-DS. We report a female child (3y 4mo) who presented with delayed psychomotor development and frequent episodes of staggering, impaired vigilance, and vomiting that resolved promptly after food intake. Electroencephalography was normal. The cerebrospinal fluid-blood glucose ratio was 0.42 (normal≥0.45). GLUT1-DS was confirmed by molecular genetic testing, which showed a novel de novo heterozygous mutation in the SLC2A1 gene (c.497_499delTCG, p.VAL166del). Before starting a ketogenic diet, the child's cognitive development was tested using the Snijders-Oomen Non-Verbal Intelligence Test, which revealed a heterogeneous intelligence profile with deficits in her visuomotor skills and spatial awareness. Her motor development was delayed. Three months after introducing a ketogenic diet, she showed marked improvement in speech and motor development, as tested by the Movement Assessment Battery for Children (manual dexterity 16th centile, ball skills 1st centile, static and dynamic balance 5th centile). This case demonstrates that GLUT1-DS should be investigated in individuals with unexplained developmental delay. Epilepsy is not a mandatory symptom. The ketogenic diet is also beneficial for non-epileptic symptoms in GLUT1-DS. |
| | |
Authors:
|
Anne Koy; Birgit Assmann; Joerg Klepper; Ertan Mayatepek |
Related Documents
:
|
17070689 - Enzymatic and non-enzymatic protective mechanisms in recalcitrant seeds of araucaria bi... 19119839 - Physicochemical and hypocholesterolemic characterization of oxidized oat beta-glucan. 22061599 - Effects of dietary supplementation of vitamins d(3) and e on quality characteristics of... 14764309 - The curcuma antioxidants: pharmacological effects and prospects for future clinical use... 15045249 - Certification of fat-soluble vitamins, carotenoids, and cholesterol in human serum: sta... 12468609 - A randomized, 4-month mango and fat supplementation trial improved vitamin a status amo... 12686019 - Use of statins for secondary prevention. 2863059 - Thermogenic capacity and brown adipose tissue activity in the common marmoset. 3826869 - Methionine toxicosis in cats. |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2011-8-12 |
Journal Detail:
|
Title: Developmental medicine and child neurology Volume: - ISSN: 1469-8749 ISO Abbreviation: - Publication Date: 2011 Aug |
Date Detail:
|
Created Date: 2011-8-15 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0006761 Medline TA: Dev Med Child Neurol Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Copyright Information:
|
© The Authors. Developmental Medicine & Child Neurology © 2011 Mac Keith Press. |
Affiliation:
|
Department of General Paediatrics, University Children's Hospital, Düsseldorf. Department of Paediatrics and Paediatric Neurology, Children's Hospital, Aschaffenburg, Germany. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Auditory processing in infancy: do early abnormalities predict disorders of language and cognitive d...
Next Document: Cerebral palsy among children born moderately preterm or at moderately low birthweight between 1980 ...